Private Advisor Group’s Serina Therapeutics SER Stock Holding History

Private Advisor Group’s Portfolio SER Stock Details SER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2	Closed	–	–	3480
2020 Q2	$0	Buy	+2	New	+$59	﹤0.01%	3931

Other funds holding SER

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

PGP

Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

SWIG

Strategic Wealth Investment Group Louisville, Kentucky $788M AUM 14.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Private Advisor Group's SER Position: Q3 2020 in Review

Private Advisor Group sold out of Serina Therapeutics (SER) in Q3 2020, closing a stake of 2 shares.

Private Advisor Group first reported a position in SER in Q2 2020 and held it in 1 quarter. The position peaked at $0 in Q2 2020. 36 funds tracked by Wall St. Rank hold SER as of Q3 2020.

Private Advisor Group reported no remaining Serina Therapeutics position as of Q3 2020 after selling out during the quarter.
Private Advisor Group sold 2 Serina Therapeutics shares in Q3 2020.
Private Advisor Group first reported a position in Serina Therapeutics in Q2 2020 and held it in 1 quarter.
Private Advisor Group's Serina Therapeutics position peaked at $0 in Q2 2020.
36 funds tracked by Wall St. Rank held Serina Therapeutics as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.